Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3

N/ACompletedNCT03572985

Taisho Pharmaceutical Co., Ltd.25 enrolled

Overview

The purpose of this study is to collect alcohol calibration data for the driving simulator.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

QUADRUPLE

Enrollment

Conditions

Healthy Participants

Interventions

Road-tracking testOTHER

Driving with simulator program for SDLP measurement

Car-following testOTHER

Driving with simulator program for DCV measurement

Harsh-braking testOTHER

Driving with simulator program for BRT measurement

Eligibility

Sex: MALEMin age: 21 YearsMax age: 64 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Body mass index (BMI) ≥18.5 and \<25.0 kg/m\^2 at screening inspection * No visual impairment (enable to correct the vision with eyeglasses or contact lens) * Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study Exclusion Criteria: * History of drug and food allergy * Alcohol dependence, drug dependence or abnormal drunken (including past history) * Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Locations (1)

Taisho Pharmaceutical Co., Ltd selected site

Fukuoka, Japan

Outcomes

Primary Outcomes

Standard Deviation of Lateral Position (SDLP)

Time frame: 60 min

Secondary Outcomes

Distance Coefficient of Variation (DCV)

Time frame: 5 min

Brake Reaction Time (BRT)

Time frame: 5 min

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.